LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Alterity Therapeutics Ltd.
Headquarters:
Melbourne, Victoria, Australia
Website:
https://alteritytherapeutic...
Year Founded:
1997
Status:
Public
Industry Sector:
HealthTechnology
CEO:
David A. Stamler, MD
Number Of Employees:
10
Enterprise Value:
$1,411,091
PE Ratio:
-2.75
Exchange/Ticker 1:
ASX:ATH
Exchange/Ticker 2:
NASDAQ:ATHE
Latest Market Cap:
$64,841,421
BioCentury
|
Mar 17, 2025
Product Development
Lundbeck’s next chapter: from psychiatry to rare neuro
Leaving past limitations behind, Danish pharma widens its technology aperture to brain shuttles, AI and more
Read More
BioCentury
|
Dec 23, 2023
Management Tracks
Pacira names Lee CEO, Hastings chair
Plus: CRISPR’s CMO to depart and a new CFO for Alterity
Read More
Items per page:
10
1 - 2 of 2